Optimizing Mild Cognitive Impairment for Discriminating Dementia Risk in the General Older Population by Stephan BCM et al.
Newcastle University e-prints  
Date deposited:  9th November 2010 [made available August 2011] 
Version of file:  Author, final 
Peer Review Status: Peer Reviewed 
Citation for published item: 
Stephan BCM, Savva GM, Brayne C, Bond J, McKeith IG, Matthews FE, Med Res Council Cognitive 
Function. Optimizing Mild Cognitive Impairment for Discriminating Dementia Risk in the General Older 
Population. American Journal of Geriatric Psychiatry 2010, 18(8), 662-673. 
Further information on publisher website: 
http://www.lww.com/ 
Publishers copyright statement: 
This paper was originally published by the Lippincott, Williams & Wilkins, 2010 and can be accessed, with 
permissions, from the DOI below: 
http://dx.doi.org/10.1097/JGP.0b013e3181e0450d 
Always use the definitive version when citing.   
Use Policy: 
The full-text may be used and/or reproduced and given to third parties in any format or medium, 
without prior permission or charge, for personal research or study, educational, or not for profit 
purposes provided that: 
• A full bibliographic reference is made to the original source 
• A link is made to the metadata record in Newcastle E-prints 
• The full text is not changed in any way. 
The full-text must not be sold in any format or medium without the formal permission of the 
copyright holders. 
 
 
 
 
Robinson Library, University of Newcastle upon Tyne,  Newcastle upon Tyne. NE1 
7RU.  Tel. 0191 222 6000 
1 
Optimising Mild Cognitive Impairment for Discriminating Dementia Risk in the 
General Older Population 
Blossom C M Stephan (PhD)
1*
, George M Savva (PhD)
1
, Carol Brayne (MD)
 1
, John Bond (BA)
 2
, Ian 
G McKeith (MD)
 3
, Fiona E Matthews (PhD)
 4
, and the Medical Research Council Cognitive Function 
and Ageing Study (MRC CFAS)
5 
1 Department of Public Health and Primary Care, Institute of Public Health, Cambridge CB2 0SR, UK 
2 Institute of Health and Society and Institute for Ageing and Health, Newcastle University 
3 Institute for Ageing and Health, Newcastle University, NE4 5PL 
4 MRC Biostatistics Unit, Institute of Public Health, Cambridge CB2 0SR, UK 
5 MRC CFAS www.cfas.ac.uk
*Address Corresponding Author: 
Blossom Stephan 
Department of Public Health and Primary Care 
Cambridge University 
Forvie Site, Robinson Way 
Cambridge, CB2 0SR, UK 
Funding  
Blossom CM Stephan is supported by the ERA-Age Future Leaders of Ageing (FLARE) Postdoctoral Fellowship. 
This work was also supported by a Medical Research Council (MRC) Project Grant and has local ethics committee 
and multi-centre ethics committee approval. FM is funded by the Medical Research Council U.1052.00.013. MRC 
CFAS has been funded by the Medical Research Council and Department of Health. The funding bodies have no 
role in the study design, data collection, analysis or decision to publish.  
Statistical Analysis: The statistical analysis was carried out by Blossom Stephan and George Savva  
KEY WORDS Mild Cognitive Impairment, Incident Dementia, Sensitivity and Specificity, Population 
Screening  
COUNTS: 
WORD COUNT (exc. Abstract) 4,571 
ABSTRACT WORD COUNT 255 
NUMBER OF TABLES 3 (Including Appendix) 
NUMBER OF FIGURES 3  
2 
ABSTRACT 
Background Criteria for Mild Cognitive Impairment (MCI) predict dementia risk in the clinic. 
Dementia risk in the population is different and whether there is an optimal MCI derived threshold for 
discriminating at-risk from not-at-risk cases in the general older population is not known. 
Methods Data were from the Medical Research Council Cognitive Function and Ageing Study (MRC 
CFAS). Two risk thresholds were derived from each of seven different concepts of MCI including: 
Mayo Clinic defined amnestic, non-amnestic, multiple and revised MCI, MCI based on Mini Mental 
State Examination (MMSE) derived categories, and the definitions of Cognitive Impairment No 
Dementia (CIND) and Age Related Cognitive Decline (ARCD). Receiver Operating Characteristic 
(ROC) analysis was used to compare the predictive validity of two-year incident dementia for each risk 
threshold across the different MCI definitions.
Findings MCI derived risk thresholds varied in their ability to predict dementia. MCI thresholds were 
accurate in identifying individuals not-at-risk of dementia progression (False Negative range, 0-3.4%). 
No MCI derived threshold accurately identified an at-risk group with a two year progression rate 
greater than 20%. Criteria for ARCD defined the threshold with the highest sensitivity and specificity 
for dementia conversion. 
Interpretation MCI derived thresholds do not reliably identify individuals at-risk of incident dementia 
at two years when applied in the general population. A large subpopulation of individuals not-at-risk 
was more reliably identified. What is considered a sufficient level of accuracy for identification of 
individuals at increased risk of dementia depends on the motivation for screening and on the safety and 
efficacy of available interventions. 
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Introduction 
The increasing incidence of dementia with the change in the world age demographic is a 
source of major public health concern. Early and accurate identification of individuals at high 
risk of dementia has become a research priority, especially with the promise of future 
preventative strategies to limit the expected rise of chronic neurodegenerative diseases 
consequent to an increased life span of the populations both in developed and developing 
countries. In the last decade identification of high risk cases has focused on the concept of 
Mild Cognitive Impairment (MCI), defined as an intermediate state between normal cognitive 
ageing and dementia. Numerous definitions for this state have been proposed, generally 
divided into those terms that capture normal age related cognitive change and those that 
capture pathological decline(1). The latter are a focus of research attention with the aim of 
identifying individuals at high risk of future dementia(2). However, it is not clear to what 
extent criteria for MCI discriminate those who will develop dementia when applied in 
population based samples. 
  
While useful as an opportunity for early dementia risk screening in clinical samples, MCI as 
currently conceptualised does not appear to transfer well to the population setting.  Studies of 
dementia incidence in MCI cohorts report up to 40-70% of cases remaining stable or reverting 
to normal cognitive function over time(3-6), with rates of progression generally depending on 
operationalisation of MCI criteria including: severity of cognitive impairment (e.g., 1, 1.5 or 2 
standard deviations (SD) below the mean), underlying neuropsychological deficit (e.g., 
amnestic, non-amnestic and multi-domain subtypes) and psychometric test choice(5, 7-12). 
Additionally, many individuals who develop dementia at follow-up are found to have had a 
level of impairment outside the MCI range at baseline, and were therefore excluded from an 
MCI case diagnosis (here called non-classified or NON-C cases)(13). This finding raises the 
question of whether a risk threshold derived from a combination of the MCI and NON-C 
groups improves dementia risk prediction in the general population.  
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Here we compare risk thresholds derived from six commonly used MCI case definitions as 
well as the Mini Mental State Examination (MMSE)(14) with respect to their ability to 
discriminate those at risk of incident dementia in the older population. Using data from the 
Medical Research Council Cognitive Function and Ageing Study (MRC CFAS) we stratified 
all non-demented individuals into three risk categories, including low, moderate and high 
based on dementia incidence for the normal, MCI and NON-C groups previously reported for 
each MCI definition(5, 13). We then compared two-year dementia incidence across different 
combinations of the three risk categories to assess the current potential use of each as a 
screening tool for predicting dementia risk.  
Methods 
Study Design and Subjects 
MRC CFAS is a large multi-centre population based prospective cohort study of individuals 
aged 65 years and older from the UK. Full details of the study design and procedures are 
published elsewhere and are briefly described here(15) (http://www.cfas.ac.uk). Individuals 
were randomly selected from the Family Health Service Authority lists in five areas in 
England and Wales including two rural (Cambridgeshire and Gwynedd) and three urban 
(Newcastle, Nottingham and Oxford). Baseline interviews were undertaken from 1991-1992. 
A two-phase screening procedure was used. At baseline screening, 13,004 individuals 
provided information on physical, behavioural and sociodemographic status in addition to 
aspects of health including self reported chronic conditions, and cognition using the MMSE. 
Individuals also completed selected items from the Geriatric Mental State (GMS) 
Examination(16). The GMS is a standardised psychiatric interview designed to detect 
dementia, depression, and other psychiatric illness in people aged 65 years and older by use of 
an algorithmic programme called the AGECAT (Automated Geriatric Examination Computer 
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Assisted Taxonomy)(16). Following the baseline interview a sub-sample of approximately 
20% (n=2,640) were selected based on age, centre and cognitive ability, and weighted toward 
the cognitively frail to participate in a more detailed assessment interview. This included full 
mood and organicity sections of the GMS in addition to more detailed cognitive assessment 
using the Cambridge Cognitive Examination (CAMCOG)(17). Information on medical 
conditions, health status and functional ability were also collected. Respondents who 
underwent further assessment were asked to complete one or two yearly follow-ups(15). Data 
from the initial prevalence screen, first assessment and two year follow-up interviews (Data 
Version 8.2, December 2006) were used in this analysis, in addition to death notifications 
from the UK National Health Service Central Register.  
Diagnosis of Dementia, Depression and Anxiety
The study diagnosis of dementia is based on the GMS AGECAT algorithm, defined as an 
organicity scale rating of 3 or above. This is comparable to dementia as diagnosed by the 
DSM-III-R(18-19). Using relevant GMS symptom items depression and anxiety were both 
defined as an AGECAT symptom level of 3 or above.  
Cognitive Assessment 
General cognitive function was assessed using the MMSE. In those definitions that required 
“normal general cognitive function” a MMSE score of 21 or less was used to indicate 
impairment(20-21). Memory and non-memory cognitive performance was evaluated using the 
subscales of the CAMCOG including: orientation, language, memory (learning, recent, and 
remote), attention and calculation, praxis, abstract thinking, and perception. Currently there is 
no consensus on the severity level (e.g., 1SD, 1.5SDs or 2SDs below the mean) for 
operationalising the MCI criterion of “objective cognitive impairment”(3, 8, 22-23). As such, 
memory impairment was defined using a cut-off score of 1SD below the mean (estimated 
using the 16
th
 percentile as subscale scores are not normally distributed), on any of the three 
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CAMCOG memory sub-tests including learning memory, recent memory and remote 
memory. Impaired memory could therefore be in a single or multiple memory domains. 
Normal memory performance was defined as a score above the -1SD cut-off value on all three 
memory sub-tests. Non-memory impairment was also defined using a cut-off score of 1SD 
below the mean (16
th
 percentile), on one or more of the following subscales including: 
orientation, language, attention/calculation, praxis, abstract thinking or perception. Normal 
non-memory performance was defined as a score above the -1SD cut-off value on all non-
memory subscales. In addition, memory and non-memory impairment was defined using a 
stricter severity level of 1.5SDs below the mean, estimated using the 7
th
 percentile. For Mayo 
Clinic defined MCI(24-25), severity scores were age standardised using five year age groups. 
Memory Complaint 
Memory complaint could be reported by the individual or their informant. A combined score 
was created from three questions including: (1) Have you had any difficulty with your 
memory?; (2) Have you tended to forget things recently?; and, (3) Has he/she had any 
difficulty with his/her memory? Answers for each question were coded into two categories 
(yes or no), from which individuals were dichotomized into non-complainers or complainers 
(positive response to one or more questions). 
Functional Disability: Activities of Daily Living (ADL) and Instrumental Activities of 
Daily Living (IADL) 
Functional disability was assessed using questions from the Modified Townsend Disability 
Scale, with an additional three items(26). Using information on a hierarchy of ADL/IADL 
disability, individuals in CFAS are classified into one of three groups. The first group 
included those individuals who showed no evidence of impairment in ADL or IADLs on 
items including washing, cooking hot meals, putting on shoes and socks, completing heavy 
housework or shopping and carrying heavy bags, and the individual can get around outside. 
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The second group included individuals with impairments only in IADLs, including those 
individuals who require regular help on items including heavy housework or shopping and 
carrying heavy bags. The third group included those individuals with deficits in basic 
activities of daily living (BADLs) including individuals who require help at least several 
times per week on items relating to washing, cooking and dressing, or if they are house/chair 
bound. ADL/IADL impairments are a key determinant of dementia and have been linked to 
cognitive, mental, physical and sensory causes. However, essentially intact functional ability 
is required in some, but not all case definitions of MCI(2), and there are currently no 
guidelines as to what is the most accurate ADL/IADL restriction for a MCI case diagnosis(3). 
For this analysis those individuals in Group 3 (impaired BADLs) were excluded at baseline. 
As such, mild IADL deficits were not an exclusion for MCI, similar to the Cardiovascular 
Health Study Cognition Study(27). 
Exclusion Criteria 
Definitions of MCI typically exclude individuals with psychiatric and vascular co-morbidity 
to help improve diagnostic accuracy(2). Individuals with anxiety or depression, or self 
reported history of stroke, heart attack, Parkinson’s disease or severe functional difficulty 
(defined above) were therefore excluded from MCI mapping. Of the 2,640 individuals at first 
assessment a total of 818 (31.0% back weighted to the UK population) non-demented 
individuals had one or more excluding conditions or missing health status information on one 
or more health variables and were excluded from our analysis. In addition, individuals with a 
diagnosis of dementia at first assessment were excluded. Of the 2,640 individuals at first 
assessment, 587 were diagnosed with dementia. 
MCI Classification 
MCI criteria included: Mayo Clinic defined, amnestic MCI (A-MCI: impairment in one or 
more memory domains)(25, 28), amnestic multi-domain MCI (M-MCI: impairment in 
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memory and non-memory domains)(29), non-amnestic MCI (N-MCI: impairment in one or 
more non-memory domains with preserved memory)(30), and revised MCI (R-MCI) that 
combined the latter three definitions, MCI based on MMSE defined categories, in addition to 
the definitions of Cognitive Impairment No Dementia (CIND)(31) and Age Related Cognitive 
Decline (ARCD)(32). The component criteria for each MCI definition vary resulting in 
different combinations of impaired/non-impaired abilities. Further, while some definitions 
have specific criteria for implementation (e.g., A-MCI), others lack operational definitions 
and explicit component criteria and therefore require interpretation as to the exact nature of 
the deficit (e.g., ARCD)(2). 
 In CFAS diagnostic criteria for Mayo Clinic defined MCI included: (1) not demented; (2) 
memory complaint reported by the individual or their informant; (3) normal general cognitive 
function; (4) no severe functional impairment; and, (5) objective memory and/or non-memory 
impairment. Mapping of the different Mayo Clinic definitions varied with regard to the last 
criterion: for A-MCI memory was required to be impaired and non-memory intact, for N-MCI 
memory was required to be intact and non-memory impaired, and for M-MCI both memory 
and non-memory test performance was required to be impaired. The definition of R-MCI 
combines all three criteria. For a diagnosis of CIND the individual was required to have a 
complaint of memory loss, impaired memory and/or non-memory performance and impaired 
general cognitive function. The definition of ARCD requires an objectively identified decline 
in general cognitive function as a consequent to the normal ageing process that is within 
normal limits for age. Further, individuals may report memory problems (e.g., with names, 
appointments or difficulty in solving complex problems). In CFAS criteria for an ARCD case 
diagnosis included impaired general cognitive function that may or may not be accompanied 
by SMC. Further, for ARCD we also required that memory test performance was not 
impaired, as memory impairment in combination with impaired general cognitive function 
was considered to be more severe than age related change. For a diagnosis of MCI based on 
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the MMSE, scores in the range of 22-26 were used to define the MCI group based on the 
results of this test alone. For each definition in order to be classified into the normal group an 
individual had to perform within normal limits on all criteria. As such NCI groups were 
defined differently depending on the MCI definition. All non-demented persons who were not 
normal but did not fulfil all MCI diagnostic criteria, such as for example a person who 
satisfies all A-MCI criteria but is classified as a non-complainer, were coded as non-classified 
(NON-C) for each definition(13). All individuals with missing MCI criterion data were 
excluded when each definition was mapped. Population based prevalence estimates and the 
two year dementia progression rates for the NCI, MCI and NON-C groups (back-weighted to 
the UK population) for each definition are shown in Table 1. 
Assigning Participants to Dementia Risk Categories 
Three dementia risk categories were defined including low, moderate and high based on the 
two year dementia progression rate for the NCI, MCI and NON-C groups outlined in Table 1. 
As shown in Table 1, across all definitions the NCI group had the lowest dementia 
progression rate and therefore was assigned the LR category. The high risk category included 
either the MCI or NON-C group depending on which had the highest dementia progression 
rate, as shaded in Table 1. The remaining group was considered to be at moderate risk. 
Based on the dementia risk categories each MCI definition therefore defines two thresholds 
for identifying at-risk individuals. The first compares the LR group to the MR and HR groups 
combined (Threshold 1: T1). This risk threshold represents a comparison between the NCI 
group to the risk defined by combining the MCI and NON-C groups. The second is the LR 
and MR groups combined compared to the HR group (Threshold 2: T2). Here, as defined 
above the high risk group for each definition is whichever of the NON-C or MCI group had 
the highest two year dementia progression rate (5, 13). The baseline demographic 
characteristics for the at-risk and not-at-risk groups defined by each risk threshold at each 
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cognitive severity level (1SD vs. 1.5SDs below the mean) are available in Supplementary 
Appendix Table A.  
Analysis 
Diagnostic accuracy for each of the two risk thresholds across the different MCI definitions 
was compared using the Receiver Operating Characteristic (ROC) method, with two year 
dementia incidence as the outcome. The ROC curve plots the sensitivity of each classification 
or the proportion of dementia cases identified, against one minus its specificity, where 
specificity is the proportion of those not developing dementia correctly identified. A perfect 
model has both sensitivity and specificity of 100%, and would be plotted in the upper left 
corner. The prognostic power of the MMSE score was also examined continuously and the 
ROC curve corresponding to using each MMSE score as a risk threshold for incident 
dementia is also included.   
To compare the groups identified as being at-risk by each risk threshold we plotted the 
positive predictive value (PPV) for the at-risk group against the number of people classified 
as being at-risk for all MCI definitions. Further, to compare the groups identified as being 
not-at-risk by each risk threshold we plotted the size of the subgroup classified as not-at-risk 
against the negative predictive value (NPV) for all MCI definitions. 
Analysis was undertaken using Stata (Version 10: Stata Corporation, College Station, Texas). 
Population based proportions were estimated from the sample using an inverse probability 
weight. This weight was applied to each individual and was the reciprocal of the probability 
of that individual being included in the analysis. The probability was estimated using 
weighted logistic regression accounting for the over-sampling in the assessment arm of older 
and more cognitively impaired participants and attrition (death and dropout) between baseline 
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and follow-up interviews. Binomial confidence intervals for proportions taking into account 
the probability weights were calculated using a Wilson score interval(33). 
Results 
There were 137 incident dementia cases over the two year follow-up period (population back-
weighted two year incidence rate=4.4%). The ROC results for each MCI definition (at both 
cognitive severity levels) for each risk threshold are presented in Table 2. As expected, for 
each definition the severity level of -1.5SDs resulted in an improvement in specificity but 
with fewer dementia cases detected, i.e., lower sensitivity. All comparisons discussed below 
are based on the -1SD severity level.  
ROC Curve A ROC plot comparing the sensitivity and specificity of each risk threshold for 
the different definitions of MCI is shown in Figure 1. As shown, definitions fall broadly into 
two classes: (1) those that are sensitive, that capture 80% or more of people who progress to 
dementia at two years with high false positive rates (including: ARCD [T1, T2], N-MCI [T2], 
MMSE24, CIND [T1] and A-MCI/N-MCI/M-MCI/R-MCI [T1]); and, (2) those that are 
specific, identifying fewer people who have progress to dementia, but with fewer false 
positives (including: R-MCI [T2], CIND [T2], M-MCI [T2], MMSE21, A-MCI [T2]). 
Overall, the component criteria for ARCD define the most sensitive and specific thresholds. 
Similar results for both risk thresholds were found due to the small number of individuals 
classified into the moderate risk group i.e., satisfy criteria for ARCD (Table 1: n=40, 
prevalence<1.5%). The MMSE provides classifications that are at least as good as, or better 
than most other MCI derived risk thresholds 
Identifying a High Risk Cohort Figure 2 compares the PPV of each at-risk group with the 
percentage of persons identified as being at-risk (see Table 2) by the two risk thresholds for 
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all MCI definitions. As shown, no method was able to identify an at-risk group with a 
dementia risk of more than 20%, apart from the very small group with an MMSE19.  
However this is considerably higher than the 4% risk seen in the general population. Overall, 
at-risk case selection was variable. For example, when using M-MCI defined thresholds, less 
than 5% of the sample was identified as being at-risk with approximately 20% of these 
individuals progressing to dementia at two years. In contrast, the thresholds defined using 
criteria for CIND identified approximately 45% of the sample as being at-risk, with dementia 
progression of 9%, roughly twice the incidence in the general population. Therefore, when 
used to predict at-risk cases, MCI defined risk thresholds are either very inclusive with low 
progression rates, or very strict with moderate progression rates. Furthermore, from the 
MMSE curve (Figure 2) diagnostic accuracy of each MCI defined threshold was not better 
than using the MMSE. 
Identifying a Low Risk Cohort Each classification defines an at-risk group, and so implicitly 
all other cases are defined as being not-at-risk. Figure 3 compares the progression rate in the 
not-at-risk group by its size for each risk threshold across the different MCI definitions. 
Generally the smaller the not-at-risk group identified, the lower the risk within that group. 
Overall, the ARCD defined thresholds identified a large not-at-risk group (approximately 
80% of individuals) with a 0.5% chance (dementia progression range 0.0-2.5%) of two year 
incident dementia. 
Discussion 
In this study we investigated a possible strategy to maximise identification of individuals at 
risk of dementia in a population based cohort. When applied in population based samples 
MCI criteria necessarily create three groups including those meeting the criteria and being 
defined as MCI, those defined as not impaired (NCI), and those identified as impaired but 
without meeting the criteria. Rather than a risk dichotomy based on a positive vs. negative 
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MCI case diagnosis, we used previously derived incident dementia rates from NCI, MCI and 
NON-C groups as the basis for three levels of risk stratification and then tested, for previously 
published MCI definitions, two different risk classification thresholds. These were compared 
with the discriminatory ability of the MMSE in the same cohort. We found that different 
definitions of MCI identified subgroups that varied with respect to their dementia risk over a 
two year period. Overall at-risk case selection was generally poor. In contrast, all MCI criteria 
accurately defined a not-at-risk threshold that captured the majority of individuals who are 
unlikely to develop two-year incident dementia. 
With regard to at-risk case selection, for most definitions, Threshold 1 where the at-risk group 
was defined as the combination of the MCI and NON-C groups was better a discriminating 
individuals at-risk of dementia, with the exception of the definition of N-MCI. For N-MCI 
discrimination of at-risk from not-at risk cases was better with Threshold 2 where the not-at-
risk group was defined as the combination of: (1) people who performed within normal limits 
on all Mayo Clinic Criteria; and, (2) people who satisfy Mayo Clinical Criteria for N-MCI 
(including subjective memory complaint, normal general cognitive function, no severe 
functional impairment, normal memory performance and impaired non-memory 
performance). Here, the at-risk group was defined as all people who fell outside the N-MCI 
range (i.e., people with single-amnestic or combined amnestic and non-amnestic 
impairments). As such, these results support previous findings that suggest that impaired 
performance in non-memory domains is not as effective at identifying individuals who 
progress to dementia if memory is not affected(5, 34).  
While risk thresholds derived from some MCI definitions identified a small proportion of 
those at-risk of dementia within two years with a high prevalence of undetected cases (e.g., A-
MCI), others were able to identify most people who developed incident dementia through 
inclusion of a very large proportion of the older population (e.g., CIND). Overall, thresholds 
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derived from the component criteria of ARCD had the highest sensitivity and specificity. For 
the definition of ARCD, the moderate risk group was defined as those with age-related 
cognitive decline, while the high risk group comprised those whose cognitive changes were 
not simply age related.  Both the low vs. moderate/high and low/moderate vs. high thresholds 
resulted in similar classification accuracy owing to few individuals being identified as at 
moderate risk (i.e., people who satisfy criteria for ARCD including impaired general 
cognitive function with normal memory test performance). The highest predictive accuracy 
was achieved using the low vs. moderate/high risk threshold, with the at risk group in this 
case including individuals with one of three possible profiles: (1) Normal MMSE/Impaired 
Memory; (2) Impaired MMSE/Normal Memory (individuals with an ARCD case diagnosis); 
and, (3) Impaired MMSE/Impaired Memory. Here the not-at risk group included all people 
with non-impaired MMSE and normal memory test performance. Given that ARCD criteria 
overlap those of Mayo Clinic defined MCI and CIND the results suggest that additional 
information used to classify individuals as MCI or CIND, for example, on subjective memory 
complaint and non-memory test performance does not improve predictive accuracy.  
Compared to more detailed MCI definitions the MMSE was generally found to have a higher 
combined sensitivity/specificity, with the exception of the thresholds derived from the 
definition of ARCD. MMSE is easy to administer in non-clinical samples and does not 
require more detailed MCI criteria. However, overall the best threshold was that derived from 
criteria of ARCD which includes further objective memory testing in addition to the MMSE. 
Whether the improvement in accuracy when using the MMSE in combination with objective 
memory testing is large enough to be justifiable, especially in terms of extra data collection 
costs will depend on the reason for screening as well as the availably of resources.   
Using stricter cut-points for cognitive severity level (-1.5SD vs. -1SDs) had the effect of 
substantially reducing the sensitivity of definitions without sufficient corresponding 
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improvement in specificity. This is not unexpected in population based samples where the 
level of ability would be expected to be more variable and generally higher than in clinic 
based samples. Overall the results suggest that for population dementia risk screening too 
strict clinical criteria fail to capture all individuals at risk. 
With regard to not-at-risk case selection the results suggest that the discriminatory power of 
the MMSE as well as several different definitions of MCI could be sufficient for identifying a 
large group of the older population as being at very low risk of dementia incidence. The 
ARCD derived thresholds were able to identify a sub-group of around 80% of individuals 
with normal age associated change, alive at two years follow-up and at 0.5% risk of dementia. 
The remaining 20% had roughly 15% risk of two year dementia incidence and can be 
considered to be at greater risk. Classification of not-at-risk cases using MCI criteria therefore 
provides a potentially useful tool to streamline future research into better methods for the 
remaining groups in who staged methods or timed re-screening may be more appropriate. 
There are some limitations to the study. The cognitive assessment was performed with the 
MMSE and CAMCOG with specific cut-off scores. Different measures and impairment 
severity levels will lead to varying results. However, there are currently no recommendations 
regarding which psychometric instrument(s) or severity level maximise screening accuracy 
and this remains to be tested. In this study, MCI was mapped retrospectively using the 
application of standardised rules and measures and therefore does not benefit from the 
flexibility of clinical judgement. However, clinical judgement adds a subjective element to 
mapping which is not replicable and consistent rules allow for direct comparison across every 
MCI definition within the same sample. Dementia progression was evaluated within a two 
year time frame and during longer follow-up more persons would be expected to progress to 
dementia. However, screening would be expected to be effective over a limited time frame. 
Shorter time frames of risk would be beneficial for targeted treatment, while longer time 
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frames of risk might be important to identify those individuals in whom it might be important 
to defer treatment and also who may have a longer window of opportunity for modification. 
Medical exclusion criteria were applied in order to be consistent with clinical mapping of 
MCI(1, 35-39). While currently there are no guidelines on what are the best eligibility criteria 
to identify a representative MCI sample the exclusion of co-morbid conditions could 
adversely affect high risk case selection and population representativeness of the sample. 
However, previous studies have been inconclusive in identifying medical risk factors for 
incident dementia in MCI(40-41). Further studies examining the two-year risk of dementia 
across cognitive states in individuals with and without health co-morbidity are therefore a 
research priority. Lastly, MCI criteria perform best at identifying at-risk cases when 
individuals with MCI are combined with persons excluded from an MCI cases diagnosis 
(NON-C cases). However, no objective criteria for identifying the NON-C group exist and 
risk in this group has not been externally validated. Given the high dementia progression rate 
in the NON-C group and the finding that at-risk case identification is generally improved 
when MCI and NON-C groups are combined, the characteristics of the NON-C group, and 
how best to define MCI so at-risk cases are not excluded from diagnosis must be explored.  
Conclusion 
If screening for MCI is to be undertaken in the population such criteria would be expected to 
classify people accurately into one of three groups as defined in this analysis: (1) those at high 
risk for referral and management/treatment, without criteria being over or under inclusive; (2) 
those at moderate risk in whom deficits are suspect and where a period of watchful waiting, 
timed re-screening or active monitoring is more clinically appropriate; and, (3) those not at 
increased risk (either high functioning or with non-pathological age associated decline) who 
can be excluded. Criteria that are too strict will cause many cases that would benefit from 
early diagnosis and further follow-up to be missed, while criteria that are too inclusive will 
17 
result in many cases inappropriately identified for intervention (such as enrolment into 
clinical trials). Currently, clinic based MCI criteria do not perform at the very high levels 
required for their application as screening tools for those at high risk of incident dementia in 
the general older population justifying a referral, but they are able to discriminate those at 
elevated risk in whom watchful waiting or a cheap low-risk intervention would be appropriate 
from those at very low risk. Different methods for at-risk case identification must be 
developed which may include the unique characteristics in each definition that clearly 
distinguish normal age associated change, non progressive and progressive MCI. 
Identification and exclusion of not-at-risk groups may present a possible targeted strategy. 
The number of persons classified as being not-at-risk is substantial, and by using an exclusion 
approach many individuals in whom preventative treatment would not be beneficial can be 
correctly excluded from clinical trials. Importantly we have shown that this is possible from a 
simple screening test such as the MMSE and more complex MCI criteria are not required.  
18 
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